JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brigstock, D
Right arrow Articles by Perbal, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brigstock, D
Right arrow Articles by Perbal, B
Journal of Clinical Pathology 2005;58:463-465
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists


EDITORIAL

CCN workshop

CCN workshop

D Brigstock1, L Lau2, B Perbal3

1 Center for Cell and Vascular Biology, Children’s Research Institute, Columbus, Ohio 43016, USA
2 Department of Biochemistry and Molecular Genetics, University of Illinois Colleage of Medicine, Chicago, IL 60607, USA
3 Laboratoire d’Oncologie Virale et Moléculaire - UFR de Biochimie, Université Paris 7 - D. Diderot, 2 Place Jussieu 75005 Paris, France

Correspondence to:
Professor B Perbal
Laboratoire d’Oncologie Virale et Moléculaire - UFR de Biochimie, Université Paris 7 - D. Diderot, 2 Place Jussieu 75005 Paris, France; perbal@ccr.jussieu.fr


Report on the Third International Workshop on the CCN Family of Genes

Keywords: cancer; differentiation; proliferation; signalling

The first 150 words of the full text of this article appear below.

The CCN family currently comprises six extracellular matrix associated proteins (CCN1–6) that regulate diverse cell functions. Although CCN molecules regulate vital processes in vivo (for example, chondrogenesis, angiogenesis, and matrix remodelling) and are associated with several pathophysiological disorders (such as fibrosis and tumorigenesis), it has been a challenge to define the underlying biological mechanisms involved. Progress has been hampered by the disparate in vivo and in vitro models used by investigators in the field, and by the difficulty in obtaining validated reagents (particularly recombinant CCN proteins) for experimental use. In spite of these drawbacks, there have been many exciting developments in the field over the past few years, and it was against this backdrop that investigators convened for the Third International Workshop on the CCN Family of Genes in St Malo, France on 20–23 October 2004.


GENE EXPRESSION
Although studies in the early 1990s showed that CCN1 and CCN2 were . . . [Full text of this article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.